1Kobune F, Funatu M, Takahashi H, et al. Characterization of measles viruses isolated after measles vaccination[J]. Vaccine, 1995, 13 (4):370 - 372.
2Huiss S, D amien B, Schneider F, et al. Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors[J]. Clin Exp Immunol, 1997,109(3):416-420.
3Muller CP. Measles elimination: old and new challenges?[J]. Vaccine, 2001,19(17/19):2258 - 2261.
4Markowitz LE, Albrecht P. Rhodes P, et al. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination karser Perranente Measles Vaccine Trial Team[J]. Pediatrics, 1996,97(1):53- 58.
5Maldonado YA, Lawrence EC, DeHovitz R, et al. Early loss of passive measles antibody in infants of mothers with vaccine -induoed immunity[J]. Pediatrics, 1995,96(3 Pt 1):447-450.
6Gans HA, Arvin AM, Galinus J, et al. Deficiency of the humoral immune response to measles vaccine in the infants immunized at age of 6 rnonths[J]. JAMA, 1998,280(6):527-532.
7Karim C, Claude P. New strategies for dosing the gap of measles susc eptibility in infants: towards vaccines compatible with current vaocination schedules[J]. Vaccine, 2001,19(17/19):2238-2244.
8Ayata M, Kimoto T, Hayashe K, et al. Nudeotide sequences of the matrix protein gene of subacute sderosing panencephalitis viruses compared with local contemporary isolates from patients with acute measles[J]. Virus Res, 1998,54(1):107-115.
9Miyamoto H, Tanaka T, Kitamoto N, et al. Detection of immunoreactive antigen with a monoclonal antibody to measles virus in tissue from a patient with Crohn's disease[J]. J Gastroenterol, 1995,30(1):28 - 33.
10Wakefield AJ, Ekbom A, Dhillon AP, et al. Crohns disease: pathogen esis and persistent measles virus infection[J]. Gastroenterology, 1995, 108(3):911 - 916.
